LINC00467, Driven by Copy Number Amplification and DNA Demethylation, Is Associated with Oxidative Lipid Metabolism and Immune Infiltration in Breast Cancer.

Journal Article (Journal Article)

Breast cancer (BRCA) is a malignant tumor with a high incidence and poor prognosis in females. However, its pathogenesis remains unclear. In this study, based on bioinformatic analysis, we found that LINC00467 was highly expressed in BRCA and was associated with tumor metastasis and poor prognosis. The genomic and epigenetic analysis showed that LINC00467 may also be regulated by copy number amplification (CNA), chromatin openness, and DNA methylation. In vitro experiments showed that it could promote the proliferation, migration, and invasion of BRCA cells. Competitive endogenous RNA (ceRNA) regulatory network analysis and weighted gene coexpression network analysis (WGCNA) suggested that LINC00467 may play a role in signaling pathways of peroxisomal lipid metabolism, immunity, and others through microRNAs (miRNAs) targeting transforming growth factor beta 2 (TGFB2). In addition, copy number amplification and high expression of LINC00467 were associated with the low infiltration of CD8+ and CD4+ T cells. In conclusion, we found that LINC00467, driven by copy number amplification and DNA demethylation, may be a potential biomarker for the diagnosis and prognosis of BRCA and a tumor promoter acting as a potential therapeutic target for BRCA as well.

Full Text

Duke Authors

Cited Authors

  • Bo, H; Zhang, W; Zhong, X; Chen, J; Liu, Y; Cheong, K-L; Fan, P; Tang, S

Published Date

  • 2021

Published In

Volume / Issue

  • 2021 /

Start / End Page

  • 4586319 -

PubMed ID

  • 34956437

Pubmed Central ID

  • PMC8695024

Electronic International Standard Serial Number (EISSN)

  • 1942-0994

Digital Object Identifier (DOI)

  • 10.1155/2021/4586319

Language

  • eng

Conference Location

  • United States